Ernexa Therapeutics Inc. has filed 1,483 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-02 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits |
| 8-K | 2026-07-02 | Regulation FD Disclosure; Financial Statements and Exhibits |
| 8-K | 2026-06-26 | Departure/Appointment of Directors or Officers; Financial Statements and Exhibits |
| SC 13G/A | 2026-05-20 | Beneficial Ownership Report (Passive, Amended) |
| SC 13G/A | 2026-05-15 | Beneficial Ownership Report (Passive, Amended) |
| SC 13G/A | 2026-05-15 | Beneficial Ownership Report (Passive, Amended) |
| SC 13G | 2026-05-14 | Beneficial Ownership Report (Passive) |
| SC 13G | 2026-05-14 | Beneficial Ownership Report (Passive) |
| SC 13G/A | 2026-05-13 | Beneficial Ownership Report (Passive, Amended) |
| DEFA14A | 2026-05-11 | Additional Proxy Soliciting Materials |